Encompass Health Corporation $EHC Stake Cut by New York State Teachers Retirement System

New York State Teachers Retirement System decreased its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 8.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 66,389 shares of the company’s stock after selling 6,451 shares during the period. New York State Teachers Retirement System owned about 0.07% of Encompass Health worth $6,422,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. lifted its holdings in Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after acquiring an additional 3,793,358 shares during the last quarter. AlphaCore Capital LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $4,881,000. Tudor Investment Corp ET AL lifted its holdings in shares of Encompass Health by 155.3% in the 3rd quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock worth $26,765,000 after purchasing an additional 128,191 shares during the last quarter. SG Americas Securities LLC boosted its position in Encompass Health by 1,070.9% during the 4th quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock valued at $9,346,000 after purchasing an additional 80,534 shares during the period. Finally, Cinctive Capital Management LP grew its stake in Encompass Health by 48.6% during the 3rd quarter. Cinctive Capital Management LP now owns 66,898 shares of the company’s stock worth $8,497,000 after buying an additional 21,887 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on EHC shares. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Barclays dropped their price objective on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. TD Cowen initiated coverage on shares of Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price for the company. Finally, Leerink Partners set a $152.00 price target on shares of Encompass Health in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $143.86.

Encompass Health Stock Up 3.3%

EHC opened at $110.52 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The company has a market capitalization of $10.96 billion, a PE ratio of 18.45, a P/E/G ratio of 2.33 and a beta of 0.74. The stock’s fifty day moving average is $103.37 and its 200-day moving average is $103.41. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. During the same quarter last year, the business posted $1.37 earnings per share. The company’s quarterly revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities analysts predict that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s payout ratio is presently 12.69%.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.80% of the stock is currently owned by corporate insiders.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.